Cited by 69Osteoarthritis Treatment and MechanismsBone Metabolism and DiseasesProteoglycans and glycosaminoglycans research

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints

Open access
Zhao, Lan, Lai, Yumei, Jiao, Hongli, Huang, Jian·2024·Nature Communications

Published version of a preprint

Abstract

Osteoarthritis (OA) is a painful, incurable disease affecting over 500 million people. Recent clinical trials of the nerve growth factor (NGF) inhibitors in OA patients have suggested adverse effects of NGF inhibition on joint structure. Here we report that nerve growth factor receptor (NGFR) is upregulated in skeletal cells during OA and plays an essential role in the remodeling and repair of osteoarthritic joints. Specifically, NGFR is expressed in osteochondral cells but not in skeletal progenitor cells and induced by TNFα to attenuate NF-κB activation, maintaining proper BMP-SMAD1 signaling and suppressing RANKL expression in mice. NGFR deficiency hyper-activates NF-κB in murine osteoarthritic joints, which impairs bone formation and enhances bone resorption as exemplified by a reduction in subchondral bone and osteophytes. In human OA cartilage, NGFR is also negatively associated with NF-κB activation. Together, this study suggests a role of NGFR in limiting inflammation for repair of diseased skeletal tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-47633-6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Inflammation, neurogenesis, and bony remodeling during OA pathogenesis and progression. a, b Representative histology images of osteoarthritic knee joint sections stained by hematoxylin and eosin. The joints were collected 2 (a) or 4 weeks (b) after the DMM surgery. Arrowheads, inflamed synovial tissues. c Representative histology images of osteoarthritic knee joint sections stained by alcian blue/hematoxylin & orange G. The joints were collected 4 weeks after the DMM surgery. Arrowheads, synovial hyperplasia and osteochondral formation. Scale bar, 100 μm. n = 6 joints. d–h Representative immunohistochemistry (IHC) images of osteoarthritic knee joint sections stained by individual antibodies as shown. The joints were collected 4 weeks after the DMM surgery. Arrowheads positively IHC signals. Scale bar, 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 1 Inflammation, neurogenesis, and bony remodeling during OA pathogenesis and progression. a, b Representative histology images of osteoarthritic knee joint sections stained by hematoxylin and eosin. The joints were collected 2 (a) or 4 weeks (b) after the DMM surgery. Arrowheads, inflamed synovial tissues. c Representative histology images of osteoarthritic knee joint sections stained by alcian blue/hematoxylin & orange G. The joints were collected 4 weeks after the DMM surgery. Arrowheads, synovial hyperplasia and osteochondral formation. Scale bar, 100 μm. n = 6 joints. d–h Representative immunohistochemistry (IHC) images of osteoarthritic knee joint sections stained by individual antibodies as shown. The joints were collected 4 weeks after the DMM surgery. Arrowheads positively IHC signals. Scale bar, 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 NGFR is significantly upregulated in skeletal cells with committed osteochondral fates compared to progenitor cells at earlier stages. a, b Western results of NGFR in mouse cells (a) and in multiple human cell lines and RCS cells (b). n = 3 independent experiments. c Perturbations of NGFR validated the anti-NGFR antibody and confirmed NGFR proteins in C2C12. sg single guide RNA for CRISPR to mutate Ngfr. CRISPRa indicates CRISPR-mediated transcriptional activation of Ngfr. Control is the empty vector for CRISPRa. Note that sg1 targeting the promoter increased NGFR expression. n = 3 independent experiments. d TrkA had no detectable protein levels in skeletal cells. * Denotes non-specific bands detected. n = 3 independent experiments. e Ngfr mRNAs were markedly increased in mouse articular chondrocytes (AC), E14.5 limb bud cells, and C2C12 cells, compared to C3H10T1/2, ATDC5, and CD45- BMSCs. Data are presented as mean values ± SD. n = 3 independent experiments. One-way ANOVA. f, g NGFR mRNAs were significantly higher in human osteoblastic cell lines (hFOB1.19 and Saos-2) than in human mesenchymal stem cells (hMSC), whereas TrkA levels are significantly lower than NGFR in all examined cells. Data are presented as mean values ± SD. n = 3 independent experiments. One-way ANOVA. h, i NGFR proteins decreased with the dedifferentiation of committed skeletal cells induced by repeated passages. n = 3. *p < 0.05, **p < 0.01, ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 2 NGFR is significantly upregulated in skeletal cells with committed osteochondral fates compared to progenitor cells at earlier stages. a, b Western results of NGFR in mouse cells (a) and in multiple human cell lines and RCS cells (b). n = 3 independent experiments. c Perturbations of NGFR validated the anti-NGFR antibody and confirmed NGFR proteins in C2C12. sg single guide RNA for CRISPR to mutate Ngfr. CRISPRa indicates CRISPR-mediated transcriptional activation of Ngfr. Control is the empty vector for CRISPRa. Note that sg1 targeting the promoter increased NGFR expression. n = 3 independent experiments. d TrkA had no detectable protein levels in skeletal cells. * Denotes non-specific bands detected. n = 3 independent experiments. e Ngfr mRNAs were markedly increased in mouse articular chondrocytes (AC), E14.5 limb bud cells, and C2C12 cells, compared to C3H10T1/2, ATDC5, and CD45- BMSCs. Data are presented as mean values ± SD. n = 3 independent experiments. One-way ANOVA. f, g NGFR mRNAs were significantly higher in human osteoblastic cell lines (hFOB1.19 and Saos-2) than in human mesenchymal stem cells (hMSC), whereas TrkA levels are significantly lower than NGFR in all examined cells. Data are presented as mean values ± SD. n = 3 independent experiments. One-way ANOVA. h, i NGFR proteins decreased with the dedifferentiation of committed skeletal cells induced by repeated passages. n = 3. *p < 0.05, **p < 0.01, ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 NGFR is positively associated with osteochondral differentiation of human skeletal progenitor cells. a The UMAP plot of 5 weeks post conception (Carnegie stage 13) human limb bud and 8 WPC (CS22) human long bone. b The dot plot showing expressions of representative genes in each cluster. Clusters 0–4 can be grouped as skeletal lineage cells based on their expression of PRRX1 and PDGFRA. c The circle plot showing the aggregated cell–cell communication network and the total interaction strength (weights) between any two skeletal cell clusters. d Violin plots showing the cumulative expression of NGFR and PRRX1 in skeletal lineage cells of CS13 limb bud and CS22 long bone. e Characterization of the expression of NGFR, SOX9, RUNX2, and ACAN in each cluster of skeletal lineage cells, split by the groups of CS13 limb bud and CS22 long bone.
Fig. 3 NGFR is positively associated with osteochondral differentiation of human skeletal progenitor cells. a The UMAP plot of 5 weeks post conception (Carnegie stage 13) human limb bud and 8 WPC (CS22) human long bone. b The dot plot showing expressions of representative genes in each cluster. Clusters 0–4 can be grouped as skeletal lineage cells based on their expression of PRRX1 and PDGFRA. c The circle plot showing the aggregated cell–cell communication network and the total interaction strength (weights) between any two skeletal cell clusters. d Violin plots showing the cumulative expression of NGFR and PRRX1 in skeletal lineage cells of CS13 limb bud and CS22 long bone. e Characterization of the expression of NGFR, SOX9, RUNX2, and ACAN in each cluster of skeletal lineage cells, split by the groups of CS13 limb bud and CS22 long bone.CC BY · PubMed Central
Fig. 4 NGFR deficiency substantially reduces subchondral bone thickening and ectopic bone formation in osteoarthritic joints. a Aggrecan-CreER efficiently targets multiple osteochondral tissues in the osteoarthritic joints, including articular cartilage (AC), subchondral area (SC), and meniscus (m). Arrowhead, targeted cells in SC. Scale bar, 100 μm. n = 3 joints. b NGFR was induced in osteoarthritic joints. Both control (Ngfr floxed) and KO (NgfrAcan-CreER) mice were injected with tamoxifen weekly to ablate Ngfr, starting 10 days after the DMM surgery. Arrowheads: NGFR+ osteochondral cells. Scale bar, 100 μm. n = 5. c NGFR loss downregulated subchondral and ectopic bone formation (arrowheads) in osteoarthritic joints. Scale bar, 200 μm. n = 12 mice. d Representative μCT 3D images of control and KO joints with OA. Arrowheads, ectopic bone. e Representative μCT 3D images of ectopic bone growth around cartilage, meniscus and synovium, as well as quantification of ectopic BV. Data are presented as mean values ± SD. n = 12 mice. Unpaired two-sided Student’s t-test. f Representative μCT 2D images of subchondral bone and BV/TV quantification of subchondral bone underneath medial tibial plateau (inside the red circles). #, ectopic bone outside subchondral area. Scale bars: 1 mm. Data are presented as mean values ± SD. n = 12 mice. Unpaired two-sided Student’s t-test. **p < 0.01, ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 4 NGFR deficiency substantially reduces subchondral bone thickening and ectopic bone formation in osteoarthritic joints. a Aggrecan-CreER efficiently targets multiple osteochondral tissues in the osteoarthritic joints, including articular cartilage (AC), subchondral area (SC), and meniscus (m). Arrowhead, targeted cells in SC. Scale bar, 100 μm. n = 3 joints. b NGFR was induced in osteoarthritic joints. Both control (Ngfr floxed) and KO (NgfrAcan-CreER) mice were injected with tamoxifen weekly to ablate Ngfr, starting 10 days after the DMM surgery. Arrowheads: NGFR+ osteochondral cells. Scale bar, 100 μm. n = 5. c NGFR loss downregulated subchondral and ectopic bone formation (arrowheads) in osteoarthritic joints. Scale bar, 200 μm. n = 12 mice. d Representative μCT 3D images of control and KO joints with OA. Arrowheads, ectopic bone. e Representative μCT 3D images of ectopic bone growth around cartilage, meniscus and synovium, as well as quantification of ectopic BV. Data are presented as mean values ± SD. n = 12 mice. Unpaired two-sided Student’s t-test. f Representative μCT 2D images of subchondral bone and BV/TV quantification of subchondral bone underneath medial tibial plateau (inside the red circles). #, ectopic bone outside subchondral area. Scale bars: 1 mm. Data are presented as mean values ± SD. n = 12 mice. Unpaired two-sided Student’s t-test. **p < 0.01, ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Loss of NGFR impairs bone formation in the context of inflammation. a NGFR ablation exacerbated the decrease of alkaline phosphatase activity induced by inflammatory cytokines. Vec, empty vector; sg2, CRISPR vector expressing single guide RNA 2 to mediate Ngfr deletion. n = 3. b, c NGFR perturbation altered SMAD1 and RANKL in TNF-α-treated cells. CRISPRa, CRISPR-mediated activation of Ngfr. n = 3 independent experiments. d–f NGFR deletion downregulated the marker gene expression in BMP-SMAD1 signaling. Data are presented as mean values ± SD. n = 2 independent experiments. Two-way ANOVA. g–i OA-induced upregulations of SMAD1 and p-SMAD1 were significantly attenuated by NGFR deficiency in OA joints. Data are presented as mean values ± SD. n = 5 independent experiments. Two-way ANOVA. j, k NGFR deletion downregulated RUNX2 protein level in OA joints. Scale bar: 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 5 Loss of NGFR impairs bone formation in the context of inflammation. a NGFR ablation exacerbated the decrease of alkaline phosphatase activity induced by inflammatory cytokines. Vec, empty vector; sg2, CRISPR vector expressing single guide RNA 2 to mediate Ngfr deletion. n = 3. b, c NGFR perturbation altered SMAD1 and RANKL in TNF-α-treated cells. CRISPRa, CRISPR-mediated activation of Ngfr. n = 3 independent experiments. d–f NGFR deletion downregulated the marker gene expression in BMP-SMAD1 signaling. Data are presented as mean values ± SD. n = 2 independent experiments. Two-way ANOVA. g–i OA-induced upregulations of SMAD1 and p-SMAD1 were significantly attenuated by NGFR deficiency in OA joints. Data are presented as mean values ± SD. n = 5 independent experiments. Two-way ANOVA. j, k NGFR deletion downregulated RUNX2 protein level in OA joints. Scale bar: 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 NGFR loss-of-function further heightens inflammation-induced bone resorption. a–c NGFR deletion induced the Rankl/Opg mRNA ratio in TNF-treated cells. Vec, empty vector; sg2, CRISPR vector expressing single guide RNA 2 to mediate Ngfr deletion. Data are presented as mean values ± SD. n = 3 independent experiments. Two-way ANOVA. d, e TRAP staining and quantification of RAW264.7 cells cultured with medium conditioned by empty vector-infected or CRISPR-mediated Ngfr deletion cells. Scale bar: 80 μm. n = 3 independent experiments. Data are presented as mean values ± SD. Unpaired two-sided Student’s t-test. f, g TRAP staining and quantification of subchondral area in control and KO joints with OA. The lower edge of subchondral area is marked by the blue curves. The bottom panels are the enlargements of the upper images as indicated by the box, in order to show subchondral area in higher resolution. Arrowheads, positive TRAP staining in subchondral area. Scale bar: 100 μm. n = 7 independent experiments. Data are presented as mean values ± SD. Unpaired two-sided Student’s t-test. h, i IHC of RANKL in the osteoarthritic joints with NGFR deficiency. Scale bar: 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are provided as a Source Data file.
Fig. 6 NGFR loss-of-function further heightens inflammation-induced bone resorption. a–c NGFR deletion induced the Rankl/Opg mRNA ratio in TNF-treated cells. Vec, empty vector; sg2, CRISPR vector expressing single guide RNA 2 to mediate Ngfr deletion. Data are presented as mean values ± SD. n = 3 independent experiments. Two-way ANOVA. d, e TRAP staining and quantification of RAW264.7 cells cultured with medium conditioned by empty vector-infected or CRISPR-mediated Ngfr deletion cells. Scale bar: 80 μm. n = 3 independent experiments. Data are presented as mean values ± SD. Unpaired two-sided Student’s t-test. f, g TRAP staining and quantification of subchondral area in control and KO joints with OA. The lower edge of subchondral area is marked by the blue curves. The bottom panels are the enlargements of the upper images as indicated by the box, in order to show subchondral area in higher resolution. Arrowheads, positive TRAP staining in subchondral area. Scale bar: 100 μm. n = 7 independent experiments. Data are presented as mean values ± SD. Unpaired two-sided Student’s t-test. h, i IHC of RANKL in the osteoarthritic joints with NGFR deficiency. Scale bar: 100 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 NGFR attenuates NF-κB activation in skeletal tissues during OA. a, b OA induces nuclear translocation of p65 in joint cells as shown by p65 IHC and quantification. Hollow arrowheads, cytoplasmic p65. Solid arrowheads, nuclear p65. Scale bar: 50 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. c, d Nuclear translocation of p65 in the joint cells induced by OA was exacerbated by NGFR deficiency. Hollow arrowheads, cytoplasmic p65. Solid arrowheads, nuclear p65. Scale bar: 50 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. e, g IHC of NGFR and p65 in human articular cartilage. OA 1 and OA 2 indicate different samples. f, h Quantification of IHC results of NGFR or nuclear p65. Data are presented as mean values ± SD. **p < 0.01. Scale bar: 50 μm. n = 5 independent experiments. Unpaired two-sided Student’s t-test. Source data are provided as a Source Data file.
Fig. 7 NGFR attenuates NF-κB activation in skeletal tissues during OA. a, b OA induces nuclear translocation of p65 in joint cells as shown by p65 IHC and quantification. Hollow arrowheads, cytoplasmic p65. Solid arrowheads, nuclear p65. Scale bar: 50 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. c, d Nuclear translocation of p65 in the joint cells induced by OA was exacerbated by NGFR deficiency. Hollow arrowheads, cytoplasmic p65. Solid arrowheads, nuclear p65. Scale bar: 50 μm. Data are presented as mean values ± SD. n = 5 independent experiments. Unpaired two-sided Student’s t-test. ****p < 0.0001. e, g IHC of NGFR and p65 in human articular cartilage. OA 1 and OA 2 indicate different samples. f, h Quantification of IHC results of NGFR or nuclear p65. Data are presented as mean values ± SD. **p < 0.01. Scale bar: 50 μm. n = 5 independent experiments. Unpaired two-sided Student’s t-test. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 8 NGF-NGFR restricts the TNF/NF-κB signaling. a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-IκBα in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-IκBα induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-κB activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file.
Fig. 8 NGF-NGFR restricts the TNF/NF-κB signaling. a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-IκBα in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-IκBα induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-κB activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 64

  1. Hunter, D. J., March, L. & Chew, M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet 396, 1711–1712 (2020). · DOI
  2. Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 64, 1697–1707 (2012). · DOI
  3. Pitsillides, A. A. & Beier, F. Cartilage biology in osteoarthritis-lessons from developmental biology. Nat. Rev. Rheumatol. 7, 654–663 (2011). · DOI
  4. Pap, T. & Korb-Pap, A. Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat. Rev. Rheumatol. 11, 606–615 (2015). · DOI
  5. Berenbaum, F., Griffin, T. M. & Liu-Bryan, R. Review: metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol 69, 9–21 (2017). · DOI
  6. Burr, D. B. & Gallant, M. A. Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol. 8, 665–673 (2012). · DOI
  7. van der Kraan, P. M. & van den Berg, W. B. Osteophytes: relevance and biology. Osteoarthritis Cartilage 15, 237–244 (2007). · DOI
  8. Malfait, A. M. & Schnitzer, T. J. Towards a mechanism-based approach to pain management in osteoarthritis. Nat. Rev. Rheumatol. 9, 654–664 (2013). · DOI
  9. Aloe, L. Rita Levi-Montalcini: the discovery of nerve growth factor and modern neurobiology. Trends Cell Biol. 14, 395–399 (2004). · DOI
  10. Iannone, F. et al. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) 41, 1413–1418 (2002). · DOI
  11. Hochberg, M. C. et al. Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal antiinflammatory drugs for hip or knee osteoarthritis: a randomized trial. Arthritis Rheumatol. 73, 1167–1177 (2021). · DOI · Paper page
  12. Wise, B. L., Seidel, M. F. & Lane, N. E. The evolution of nerve growth factor inhibition in clinical medicine. Nat. Rev. Rheumatol. 17, 34–46 (2021). · DOI
  13. Hochberg, M. C. et al. When is osteonecrosis not osteonecrosis?: adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis Rheumatol. 68, 382–391 (2016). · DOI
  14. Lievense, A. M., Bierma-Zeinstra, S. M., Verhagen, A. P., Verhaar, J. A. & Koes, B. W. Prognostic factors of progress of hip osteoarthritis: a systematic review. Arthritis Rheum. 47, 556–562 (2002). · DOI
  15. Shu, X. Q. & Mendell, L. M. Neurotrophins and hyperalgesia. Proc. Natl. Acad. Sci. USA 96, 7693–7696 (1999). · DOI · Paper page
  16. Verdi, J. M. et al. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 12, 733–745 (1994). · DOI
  17. Huang, J., Zhao, L. & Chen, D. Growth factor signalling in osteoarthritis. Growth Factors 36, 187–195 (2018). · DOI
  18. Huang, J. et al. The microRNAs miR-204 and miR-211 maintain joint homeostasis and protect against osteoarthritis progression. Nat. Commun. 10, 2876 (2019). · DOI
  19. Liao, L. et al. Acute synovitis after trauma precedes and is associated with osteoarthritis onset and progression. Int. J. Biol. Sci. 16, 970–980 (2020). · DOI
  20. Denk, F., Bennett, D. L. & McMahon, S. B. Nerve growth factor and pain mechanisms. Annu. Rev. Neurosci. 40, 307–325 (2017). · DOI
  21. Quirici, N. et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. 30, 783–791 (2002). · DOI
  22. Tormin, A. et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117, 5067–5077 (2011). · DOI · Paper page
  23. Mabuchi, Y. et al. LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Rep. 1, 152–165 (2013). · DOI
  24. Severe, N. et al. Stress-induced changes in bone marrow stromal cell populations revealed through single-cell protein expression mapping. Cell Stem Cell 25, 570–583.e577 (2019). · DOI
  25. Lee, K. F. et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749 (1992). · DOI
  26. Bogenmann, E. et al. Generation of mice with a conditional allele for the p75(NTR) neurotrophin receptor gene. Genesis 49, 862–869 (2011). · DOI
  27. Glasson, S. S., Blanchet, T. J. & Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15, 1061–1069 (2007). · DOI
  28. Sanchez-Lopez, E., Coras, R., Torres, A., Lane, N. E. & Guma, M. Synovial inflammation in osteoarthritis progression. Nat. Rev. Rheumatol. 18, 258–275 (2022). · DOI
  29. Zhao, L. et al. Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis. Ann. Rheum. Dis. 78, 676–682 (2019). · DOI
  30. Wu, M., Chen, G. & Li, Y. P. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 4, 16009 (2016). · DOI · Paper page
  31. Reznikoff, C. A., Brankow, D. W. & Heidelberger, C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33, 3231–3238 (1973).
  32. Ogawa, M. et al. B cell ontogeny in murine embryo studied by a culture system with the monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the embryonal body rather than in the yolk sac. EMBO J. 7, 1337–1343 (1988). · DOI
  33. Atsumi, T., Miwa, Y., Kimata, K. & Ikawa, Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30, 109–116 (1990). · DOI
  34. Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253–1260 (2008). · DOI
  35. He, J. et al. Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses. Cell Res. 31, 742–757 (2021). · DOI
  36. Duchamp de Lageneste, O. et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat. Commun. 9, 773 (2018). · DOI
  37. Zhou, X. et al. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet. 10, e1004820 (2014). · DOI
  38. Ono, N., Ono, W., Nagasawa, T. & Kronenberg, H. M. A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat. Cell Biol. 16, 1157–1167 (2014). · DOI
  39. Scanzello, C. R. et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 17, 1040–1048 (2009). · DOI
  40. Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 21, 16–21 (2013). · DOI · Paper page
  41. Zhao, B. TNF and bone remodeling. Curr Osteoporos Rep 15, 126–134 (2017). · DOI
  42. Zhao, L. et al. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells 29, 1601–1610 (2011). · DOI
  43. Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-κB: a blossoming of relevance to human pathobiology. Cell 168, 37–57 (2017). · DOI
  44. Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156–163 (2007). · DOI
  45. Wei, J. L. et al. Role of ADAMTS-12 in protecting against inflammatory arthritis in mice by interacting with and inactivating proinflammatory connective tissue growth factor. Arthritis Rheumatol. 70, 1745–1756 (2018). · DOI
  46. Bouta, E. M. et al. Brief Report: treatment of tumor necrosis factor-transgenic mice with anti-tumor necrosis factor restores lymphatic contractions, repairs lymphatic vessels, and may increase monocyte/macrophage egress. Arthritis Rheumatol. 69, 1187–1193 (2017). · DOI
  47. Perry, M. J., Gujra, S., Whitworth, T. & Tobias, J. H. Tamoxifen stimulates cancellous bone formation in long bones of female mice. Endocrinology 146, 1060–1065 (2005). · DOI
  48. Zhang, Z. et al. Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice. Elife 10, https://doi.org/10.7554/eLife.63333 (2021). · DOI
  49. Tomlinson, R. E. et al. NGF-TrkA signaling in sensory nerves is required for skeletal adaptation to mechanical loads in mice. Proc. Natl Acad. Sci. USA 114, E3632–e3641 (2017). · DOI
  50. Li, Z. et al. Fracture repair requires TrkA signaling by skeletal sensory nerves. J. Clin. Investig. 129, 5137–5150 (2019). · DOI
  51. Lee, S. et al. NGF-TrkA signaling dictates neural ingrowth and aberrant osteochondral differentiation after soft tissue trauma. Nat. Commun. 12, 4939 (2021). · DOI
  52. Xu, J. et al. NGF-p75 signaling coordinates skeletal cell migration during bone repair. Sci. Adv. 8, eabl5716 (2022). · DOI
  53. Henry, S. P. et al. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 47, 805–814 (2009). · DOI
  54. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010). · DOI · Paper page
  55. Zhao, L. et al. Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation. J. Bone Miner. Res. 25, 1246–1256 (2010). · DOI
  56. Cao, H. et al. Activating transcription factor 4 regulates osteoclast differentiation in mice. J. Clin. Investig. 120, 2755–2766 (2010). · DOI
  57. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014). · DOI · Paper page
  58. Huang, J., Zhao, L., Xing, L. & Chen, D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28, 357–364 (2010). · DOI
  59. Huang, J., Lai, Y., Li, J. & Zhao, L. Loss of miR-204 and miR-211 shifts osteochondral balance and causes temporomandibular joint osteoarthritis. J. Cell. Physiol. https://doi.org/10.1002/jcp.31120 (2023). · DOI
  60. Fan, Y. et al. Serum miRNAs are potential biomarkers for the detection of disc degeneration, among which miR-26a-5p suppresses Smad1 to regulate disc homeostasis. J. Cell. Mol. Med. 23, 6679–6689 (2019). · DOI
  61. Fan, Y., Zhao, L., Lai, Y., Lu, K. & Huang, J. CRISPR-Cas9-mediated loss of function of β-catenin attenuates intervertebral disc degeneration. Mol. Ther. Nucleic Acids 28, 387–396 (2022). · DOI
  62. Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358–364 (2006). · DOI
  63. Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01767-y (2023). · DOI · Paper page
  64. Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Zhao, L., Lai, Y., Jiao, H., & Huang, J.
Affiliations
Rush University Medical Center (US)
Corresponding author
Huang, Jian
Venue
Nature Communications
Published
2024-04-15
Volume
15
Issue
1
Pages
3225-3225
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4394818993
Cited by
69
References
5
Citations by year
2026: 28 · 2025: 30 · 2024: 11
FWCI
22.34
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070222, R01AR070222-04S1)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Keywords
nerve growth factor receptor, osteoarthritis, joint remodeling, joint repair, NF-κB activation, TNF-α, RANKL, subchondral bone, osteophytes, bone formation, bone resorption, cartilage, inflammation, skeletal progenitor cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review